Characterising HIV-1 transmission in Victoria, Australia: a molecular epidemiological study

Authors:

• Taiaroa, George
• Chibo, Doris
• Herman, Sophie
• Taouk, Mona L.
• Gooey, Megan
• D'Costa, Jodie
• Sameer, Rizmina
• Richards, Nicole
• Lee, Elaine
• Macksabo, Lydya
• Higgins, Nasra
• Price, David J.
• Jen Low, Soo
• Steinig, Eike
• Martin, Genevieve E.
• Moso, Michael A.
• Caly, Leon
• Prestedge, Jacqueline
• Fairley, Christopher K.
• Chow, Eric P.F.
• Chen, Marcus Y.
• Duchene, Sebastian
• Hocking, Jane S.
• Lewin, Sharon R.
• Williamson, Deborah A.

Details:

The Lancet Regional Health - Western Pacific, Volume 47, 2024-06-30

Article Link: Click here

Background In Australia the incidence of HIV has declined steadily, yet sustained reduction of HIV transmission in this setting requires improved public health responses. As enhanced public health responses and prioritisation of resources may be guided by molecular epidemiological data, here we aimed to assess the applicability of these approaches in Victoria, Australia. Methods A comprehensive collection of HIV-1 pol sequences from individuals diagnosed with HIV in Victoria, Australia, between January 1st 2000 and December 31st 2020 were deidentified and used as the basis of our assessment. These sequences were subtyped and surveillance drug resistance mutations (SDRMs) identified, before definition of transmission groups was performed using HIV-TRACE (0.4.4). Phylodynamic methods were applied using BEAST (2.6.6), assessing effective reproductive numbers for large groups, and additional demographic data were integrated to provide a high resolution view of HIV transmission in Victoria on a decadal time scale. Findings Based on standard settings for HIV-TRACE, 70% (2438/3507) of analysed HIV-1 pol sequences were readily assigned to a transmission group. Individuals in transmission groups were more commonly males (aOR 1.50), those born in Australia (aOR 2.13), those with probable place of acquisition as Victoria (aOR 6.73), and/or those reporting injectable drug use (aOR 2.13). SDRMs were identified in 375 patients (10.7%), with sustained transmission of these limited to a subset of smaller groups. Informative patterns of epidemic growth, stabilisation, and decline were observed; many transmission groups showed effective reproductive numbers (R e ) values reaching greater than 4.0, representing considerable epidemic growth, while others maintained low R e values. Interpretation This study provides a high resolution view of HIV transmission in Victoria, Australia, and highlights the potential of molecular epidemiology to guide and enhance public health responses in this setting. This informs ongoing discussions with community groups on the acceptability and place of molecular epidemiological approaches in Australia. Funding National Health and Medical Research Council, Australian Research Council.